medical_xpress
@zpcbeqyqyryncom
CRISPR/Cas9-edited immune cells targeting the CISH gene demonstrate safety and early potential in halting advanced gastrointestinal #Cancer progression in initial clinical testing. @umnmedschool @TheLancetOncol https://t.co/0ih0zEfY9v https://t.co/8dn1UekUlr
0 reply
0 recast
0 reaction